The PreventCD Study design: Towards new strategies for the prevention of coeliac disease

European Journal of Gastroenterology and Hepatology

Volumn 22, Issue 12, 2010, Pages 1424-1430

  Hogen Esch, Caroline Elisabeth ^a   Rosén, Anna ^c   Auricchio, Renata ^d   Romanos, Jihane ^b   Chmielewska, Anna ^e   Putter, Hein ^a   Ivarsson, Anneli ^c   Szajewska, Hania ^e   Koning, Frits ^a   Wijmenga, Cisca ^a   Troncone, Riccardo ^d   Mearin, Maria Luisa ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UMEÅ UNIVERSITY   (Sweden)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

breast feeding; coeliac disease; infant nutrition; primary prevention; risk factors

Indexed keywords

BIOLOGICAL MARKER; GLUTEN;

ARTICLE; AUTOIMMUNE DISEASE; BREAST FEEDING; BREAST MILK; CELIAC DISEASE; CHILD; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DOUBLE BLIND PROCEDURE; ENVIRONMENTAL FACTOR; FEMALE; FOLLOW UP; HUMAN; IMMUNOLOGICAL TOLERANCE; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEWBORN; POPULATION RESEARCH; PRESCHOOL CHILD; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SCHOOL CHILD; SERODIAGNOSIS; SWEDEN;

BOTTLE FEEDING; BREAST FEEDING; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; DIET; DOUBLE-BLIND METHOD; ENVIRONMENT; EUROPE; GENETIC PREDISPOSITION TO DISEASE; GLUTENS; HLA ANTIGENS; HUMANS; IMMUNE TOLERANCE; INFANT; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; INFANT, NEWBORN; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 78349283412     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32833fe9ae     Document Type: Article

References (51)

1. Armstrong MJ, Robins GG, Howdle PD. Recent advances in coeliac disease. Curr Opin Gastroenterol 2009; 25:100-109.
2. Spaenij-Dekking L, Kooy-Winkelaar Y, Van Veelen P, Drijfhout JW, Jonker H, van Soest L, et al. Natural variation in toxicity of wheat: potential for selection of nontoxic varieties for celiac disease patients. Gastroenterology 2005; 129:797-806.
3. Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med 1989; 169:345-350.
4. Green PH, Jabri B. Coeliac disease. Lancet 2003; 362:383-391.
5. Dicke WK. Coeliac disease: investigation of the harmful effects of certain types of cereal on patients with coeliac disease (Thesis). The Netherlands: University of Utrecht; 1950.
6. Dicke WK. Treatment of celiac disease. Ned Tijdschr Geneeskd 1951; 95:124-130. (in Dutch).
7. Hopman EG, Koopman HM, Wit JM, Mearin ML Dietary compliance and health-related quality of life in patients with coeliac disease. Eur J Gastroenterol Hepatol 2009; 21:1056-1061.
8. Catassi C, Ratsch IM, Fabiani E, Rossini M, Bordicchia F, Candela F, et al. Coeliac disease in the year 2000: exploring the iceberg. Lancet 1994; 343:200-203.
9. Csizmadia CG, Mearin ML, von Blomberg BM, Brand R, Verloove-Vanhorick SP. An iceberg of childhood coeliac disease in The Netherlands. Lancet 1999; 353:813-814.
10. Biagi F, Corazza GR. Mortality in celiac disease. Nat Rev Gastroenterol Hepatol 2010; 7:158-162.
11. Ludvigsson JF, Montgomery SM, Ekbom A, Brandt L, Granath F. Small-intestinal histopathology and mortality risk in celiac disease. JAMA 2009; 302:1171-1178.
12. Van Doorn RK, Winkler LM, Zwinderman KH, Mearin ML, Koopman HM. CDDUX: a disease-specific health-related quality-of-life questionnaire for children with celiac disease. J Pediatr Gastroenterol Nutr 2008; 47:147-152.
13. Shamir R, Hernell O, Leshno M. Cost-effectiveness analysis of screening for celiac disease in the adult population. Med Decis Making 2006; 26:282-293.
14. Troncone R, Ivarsson A, Szajewska H, Mearin ML. Review article: future research on coeliac disease-a position report from the European multistakeholder platform on coeliac disease (CDEUSSA). Aliment Pharmacol Ther2008; 27:1030-1043.
15. Nistico L, Fagnani C, Coto I, Percopo S, Cotichini R, Limongelli MG, et al. Concordance, disease progression, and heritability of coeliac disease in Italian twins. Gut 2006; 55:803-808.
16. Van Heel DA, Hunt K, Greco L, Wijmenga C. Genetics in coeliac disease. Best Pract Res Clin Gastroenterol 2005; 19:323-339.
17. Van Heel DA, Franke L, Hunt KA, Gwilliam R, Zhernakova A, Inouye M, et al. A genome-wide association studyforceliac disease identifies riskvariants in the region harboring IL2 and IL21. Nat Genet 2007; 39:827-829.
18. Trynka G, Zhernakova A, Romanos J, Franke L, Hunt KA, Turner G, et al. Coeliac disease-associated riskvariants in TNFAIP3 and REL implicate altered NF-kappaB signalling. Gut2009; 58:1078-1083.
19. Hunt KA, Zhernakova A, Turner G, Heap GA, Franke L, Bruinenberg M, et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet 2008; 40:395-402.
20. Dubois PC, Trynka G, Franke L, Hunt KA, Romanos J, Curtotti A, et al. Multiple common variants for celiac disease influencing immune gene expression. Nat Genet 2010; 42:295-302.
21. Ventura A, Magazu G, Gerarduzzi T, Greco L. Coeliac disease and the risk of autoimmune disorders. Gut 2002; 51:897-898.
22. Cosnes J, Cellier C, Viola S, Colombel JF, Michaud L, Sarles J, et al. Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free diet. Clin Gastroenterol Hepatol 2008; 6:753-758.
23. Ziegler AG, Schmid S, Huber D, Hummel M, Bonifacio E. Early infant feeding and riskofdeveloping type 1 diabetes-associated autoantibodies. JAMA 2003; 290:1 721-1728.
24. Zhernakova A, van Diemen CC, Wijmenga C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet 2009; 10:43-55.
25. Van den Boom SA, Kimber AC, Morgan JB. Weaning practices in children upto19 months of age in Madrid. Acta Paediatr 1995; 84:853-858.
26. Falth-Magnusson K, Franzen L, Jansson G, Laurin P, Stenhammar L. Infant feeding history shows distinct differences between Swedish celiac and reference children. Pediatr Allergy Immunol 1996; 7:1-5.
27. Ascher H, Krantz I, Rydberg L, Nordin P, Kristiansson B. Influence of infant feeding and gluten intake on coeliac disease. Arch Dis Child 1997; 76:113-117.
28. Challacombe DN, Mecrow IK, Elliott K, Clarke FJ, Wheeler EE. Changing infant feeding practices and declining incidence of coeliac disease in West Somerset. Arch Dis Child 1997; 77:206-209.
29. Mitt K, Uibo O. Low cereal intake in Estonian infants: the possible explanation for the low frequency of coeliac disease in Estonia. Eur J Clin Nutr 1998; 52:85-88.
30. Ivarsson A, Persson LA, Nystrom L, Ascher H, Cavell B, Danielsson L, et al. Epidemic of coeliac disease in Swedish children. Acta Paediatr 2000; 89:165-171.
31. Ivarsson A, Hernell O, Stenlund H, Persson LA. Breast-feeding protects against celiac disease. Am J Clin Nutr 2002; 75:914-921.
32. Norris JM, Barriga K, Hoffenberg EJ, Taki I, Miao D, Haas JE, et al. Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. JAMA 2005; 293:2343-2351.
33. Verhasselt V Oral tolerance in neonates: from basics to potential prevention of allergic disease. Mucosal Immunol 2010; 3:326-333.
34. Olsson C, Hernell O, Hornell A, Lonnberg G, Ivarsson A. Difference in celiac disease risk between Swedish birth cohorts suggests an opportunity for primary prevention. Pediatrics 2008; 122:528-534.
35. Ivarsson A. The Swedish epidemic of coeliac disease explored using an epidemiological approach-some lessons to be learnt. Best Pract Res Clin Gastroenterol 2005; 19:425-440.
36. Akobeng AK, Ramanan AV, Buchan I, Heller RF. Effect of breast feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies. Arch Dis Child 2006; 91:39-43.
37. Silano M, Agostoni C, Guandalini S. Effect of the timing of gluten introduction on the development of celiac disease. World J Gastroenterol 2010; 16:1939-1942.
38. World Health Organization. The optimal duration of exclusive breastfeeding. Report of an expert consultation. Geneva, 28-31 March 2001 (WHO/FCH/CAH/01.24). www.who.int/child-adolescent-health/New-Publications/ NUTRITION WHO-CAH-01-24.pdf[Accessed 23 Aug 2002].
39. Babron MC, Nilsson S, Adamovic S, Naluai AT, Wahlstrom J, Ascher H, et al. Meta and pooled analysis of European coeliac disease data. Eur J Hum Genet2003; 11:828-834.
40. Hopman EG, Kiefte-de Jong JC, le Cessie S, Moll HA, Witteman JC, Bleeker SE, et al. Food questionnaire for assessment of infant gluten consumption. Clin Nutr 2007; 26:264-271.
41. Catassi C, Fabiani E, Iacono G, D'Agate C, Francavilla R, Biagi F, et al. A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. Am J Clin Nutr 2007; 85:160-166.
42. Catassi C, Rossini M, Ratsch IM, Bearzi I, Santinelli A, Castagnani R, et al. Dose dependent effects of protracted ingestion of small amounts of gliadin in coeliac disease children: a clinical and jejunal morphometric study. Gut 1993; 34:1515-1519.
43. Spaenij-Dekking EH, Kooy-Winkelaar EM, Nieuwenhuizen WF, Drijfhout JW, Koning F. A novel and sensitive method for the detection of T cell stimulatory epitopes of alpha/beta-and gamma-gliadin. Gut 2004; 53:1267-1273.
44. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 1992; 102:330-354.
45. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999; 11:1185-1194.
46. Bourgey M, Calcagno G,Tinto N, Gennarelli D, Margaritte-Jeannin P, Greco L, et al. HLA related genetic riskfor coeliac disease. Gut 2007; 56:1054-1059.
47. Myleus A, Ivarsson A, Webb C, Danielsson L, Hernell O, Hogberg L, et al. Celiac disease revealed in 3% of Swedish 12-year-olds born during an epidemic. J Pediatr Gastroenterol Nutr 2009; 49:170-176.
48. Carlsson A, Agardh D, Borulf S, Grodzinsky E, Axelsson I, Ivarsson SA. Prevalence of celiac disease: before and after a national change in feeding recommendations. Scand J Gastroenterol 2006; 41:553-558.
49. Romanos J, van Diemen CC, Nolte IM, Trynka G, Zhernakova A, Fu J, et al. Analysis of HLA and non-HLA alleles can identify individuals at high risk for celiac disease. Gastroenterology 2009; 137:834-840.
50. Monsuur AJ, de Bakker PI, Zhernakova A, Pinto D, Verduijn W, Romanos J, et al. Effective detection of human leukocyte antigen risk alleles in celiac disease using tag single nucleotide polymorphisms. PLoS One 2008; 3:e2270.
51. Ivarsson A, Myleus A, Wall S. Towards preventing celiac disease-an epidemiological approach. In: Fasano A, Troncone R, Branski D. editors. Pediatric and adolescent medicine. New frontiers in celiac disease. Basel, Switzerland: Karger Publishers; 2008. pp. 198-209.